DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

The vast majority of positive tests have come from people in Bangor who have either been homeless, injection drug users, or ...

Proposed Medicaid cuts could threaten lifesaving HIV treatment access, warns Avenue 360. HOUSTON — With President Trump's " ...